Genome-wide analysis of DNA copy number alterations and loss of heterozygosity in intracranial germ cell tumors

Pediatric Blood and Cancer

Volumn 61, Issue 4, 2014, Pages 593-600

  Terashima, Keita ^a,i   Yu, Alexander ^a   Chow, Wing Yuk T ^a   Hsu, Wei chun J ^a   Chen, Peikai ^b   Wong, Stephen ^c   Hung, Yeung Sam ^b   Suzuki, Tomonari ^d   Nishikawa, Ryo ^d   Matsutani, Masao ^d   Nakamura, Hideo ^e   Ng, Ho Keung ^f   Allen, Jeffrey C ^g   Aldape, Kenneth D ^h   Su, Jack M ^a   Adesina, Adekunle M ^a   Leung, Hon chiu E ^a   Man, Tsz Kwong ^a   Lau, Ching C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

^e KUMAMOTO UNIVERSITY   (Japan)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^g NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

ⁱ NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

DNA copy number; Genomic profiling; Intracranial germ cell tumor; Loss of heterozygosity; SNP microarray

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CANCER TISSUE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE; GENE DOSAGE; GENE IDENTIFICATION; GENE REPLICATION; GENOME ANALYSIS; GERM CELL TUMOR; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INTRACRANIAL GERM CELL TUMOR; INTRACRANIAL TUMOR; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; YOUNG ADULT;

DNA COPY NUMBER; GENOMIC PROFILING; INTRACRANIAL GERM CELL TUMOR; LOSS OF HETEROZYGOSITY; SNP MICROARRAY;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; FEMALE; FOLLOW-UP STUDIES; GENOME, HUMAN; HUMANS; INFANT; INFANT, NEWBORN; LOSS OF HETEROZYGOSITY; MALE; MUTATION; NEOPLASMS, GERM CELL AND EMBRYONAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84893497526     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24833     Document Type: Article

References (30)

1. Fujimaki T. Central nervous system germ cell tumors: Classification, clinical features, and treatment with a historical overview. J Child Neurol 2009; 24:1439-1445.
2. Matsutani M. Pineal germ cell tumors. Prog Neurol Surg 2009; 23:76-85.
3. Aoyama H, Shirato H, Ikeda J, et al. Induction chemotherapy followed by low-dose involved-field radiotherapy for intracranial germ cell tumors. J Clin Oncol 2002; 20:857-865.
4. Calaminus G, Kortmann R, Worch J, et al. SIOP CNS GCT 96: Final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro Oncol 2013; 15:788-796.
5. Packer RJ, Cohen BH, Cooney K. Intracranial germ cell tumors. Oncologist 2000; 5:312-320.
6. Echevarria ME, Fangusaro J, Goldman S., Pediatric central nervous system germ cell tumors: A review. Oncologist 2008; 13:690-699.
7. Sawamura Y, Ikeda J, Shirato H, et al. Germ cell tumours of the central nervous system: Treatment consideration based on 111 cases and their long-term clinical outcomes. Eur J Cancer 1998; 34:104-110.
8. Matsutani M, Sano K, Takakura K, et al. Primary intracranial germ cell tumors: A clinical analysis of 153 histologically verified cases. J Neurosurg 1997; 86:446-455.
9. Fouladi M, Grant R, Baruchel S, et al. Comparison of survival outcomes in patients with intracranial germinomas treated with radiation alone versus reduced-dose radiation and chemotherapy. Childs Nerv Syst 1998; 14:596-601.
10. Biegel JA. Cytogenetics and molecular genetics of childhood brain tumors. Neuro Oncol 1999; 1:139-151.
11. Bhattacharjee MB, Armstrong DD, Vogel H, et al. Cytogenetic analysis of 120 primary pediatric brain tumors and literature review. Cancer Genet Cytogenet 1997; 97:39-53.
12. Rickert CH, Simon R, Bergmann M, et al. Comparative genomic hybridization in pineal germ cell tumors. J Neuropathol Exp Neurol 2000; 59:815-821.
13. Schneider DT, Zahn S, Sievers S, et al. Molecular genetic analysis of central nervous system germ cell tumors with comparative genomic hybridization. Mod Pathol 2006; 19:864-873.
14. Wang HW, Wu YH, Hsieh JY, et al. Pediatric primary central nervous system germ cell tumors of different prognosis groups show characteristic miRNome traits and chromosome copy number variations. BMC Genomics 2010; 11:132.
15. Beroukhim R, Getz G, Nghiemphu L, et al. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma. Proc Natl Acad Sci USA 2007; 104:20007-20012.
16. Dettman EJ, Simko SJ, Ayanga B, et al. Prdm14 initiates lymphoblastic leukemia after expanding a population of cells resembling common lymphoid progenitors. Oncogene 2011; 30:2859-2873.
17. Dettman EJ, Justice MJ. The zinc finger SET domain gene Prdm14 is overexpressed in lymphoblastic lymphomas with retroviral insertions at Evi32. PLoS ONE 2008; 3:e3823.
18. Yamaji M, Seki Y, Kurimoto K, et al. Critical function of Prdm14 for the establishment of the germ cell lineage in mice. Nat Genet 2008; 40:1016-1022.
19. Nishikawa N, Toyota M, Suzuki H, et al. Gene amplification and overexpression of PRDM14 in breast cancers. Cancer Res 2007; 67:9649-9657.
20. Ruark E, Seal S, McDonald H, et al. Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14. Nat Genet 2013; 45:686-689.
21. Kranenburg O. The KRAS oncogene: Past, present, and future. Biochim Biophys Acta 2005; 1756:81-82.
22. von Eyben FE. Chromosomes, genes, and development of testicular germ cell tumors. Cancer Genet Cytogenet 2004; 151:93-138.
23. Lee J, Kanatsu-Shinohara M, Morimoto H, et al. Genetic reconstruction of mouse spermatogonial stem cell self-renewal in vitro by Ras-cyclin D2 activation. Cell Stem Cell 2009; 5:76-86.
24. Kurimoto K, Yamaji M, Seki Y, et al. Specification of the germ cell lineage in mice: A process orchestrated by the PR-domain proteins, Blimp1 and Prdm14. Cell Cycle 2008; 7:3514-3518.
25. Santagata S, Hornick JL, Ligon KL. Comparative analysis of germ cell transcription factors in CNS germinoma reveals diagnostic utility of NANOG. Am J Surg Pathol 2006; 30:1613-1618.
26. Ezeh UI, Turek PJ, Reijo RA, et al. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 2005; 104:2255-2265.
27. Murty VV, Bosl GJ, Houldsworth J, et al. Allelic loss and somatic differentiation in human male germ cell tumors. Oncogene 1994; 9:2245-2251.
28. Nevins JR. The Rb/E2F pathway and cancer. Hum Mol Genet 2001; 10:699-703.
29. Yu IT, Griffin CA, Phillips PC, et al. Numerical sex chromosomal abnormalities in pineal teratomas by cytogenetic analysis and fluorescence in situ hybridization. Lab Invest 1995; 72:419-423.
30. Arens R, Marcus D, Engelberg S, et al. Cerebral germinomas and Klinefelter syndrome. A review. Cancer 1988; 61:1228-1231.